Next Science Ltd. engages in the research, development, and distribution of technologies with bacterial issue application. It operates through the North America, Australia and New Zealand geographical segments. The company was founded by Matthew Myntti on October 20, 2017 and is headquartered in Sydney, Australia.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
N/A
Frequently Asked Questions
Market cap, also known as market capitalization, is the total market value of a company. It's calculated by multiplying the current market price by the total number of shares outstanding. Next Science Limited market cap is $292,600.00.
52 week high is the highest price of a stock in the past 52 weeks, or one year. Next Science Limited 52 week high is $0.1133 as of November 15, 2026.
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Next Science Limited 52 week low is $0.0002 as of November 15, 2026.
Next Science Limited stock price today is $0.001.
Next Science Limited stock price yesterday was $0.0002.
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It's calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company's Market Cap by the Net Profit. Next Science Limited's P/E ratio is -0.03.
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It's calculated by dividing a company's market capitalization by its book value. Next Science Limited P/B ratio is -0.5236.
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It's calculated by averaging the closing stock price over the previous 50 trading days. Next Science Limited 50-day moving average is $0.0602.
